Neuromed IRCCS   Report issue

Academic/Hospital Phase 1
Founded: Pozzilli Italy (1976)

Organization Overview

First Clinical Trial
2017
NCT03228524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

IRCCS Neuromed | Neuromed IRCCS